Hepatitis C virus (HCV) is a major global health burden accounting for around 170 million
chronic infections worldwide. Since its discovery, which dates back to about 30 years ago …

Globally, more than 58 million people are chronically infected with Hepatitis C virus (HCV)
with 1.5 million new infections occurring each year. An effective vaccine for HCV is therefore …

Hepatitis C virus (HCV) infection is a blood-borne disease that infects~ 185 million people (~
3% of the world's population) worldwide. It can result in severe liver disease and is the …

Viral hepatitis is a major public health concern in China, but data on national
epidemiological characteristics are lacking. We collected reporting incidence data on …

Hepatitis C virus (HCV) is a blood-borne pathogen that has a worldwide distribution and
infects millions of people. Care-associated HCV infections represented a huge part of …

Introduction: With more than 150 million chronically infected people, hepatitis C virus (HCV)
remains a substantial global health burden. Direct-acting antivirals have dramatically …

Vaccination has essentially eradicated poliovirus. Yet, its mutation rate is higher than that of
viruses like HIV, for which no effective vaccine exists. To investigate this, we infer a fitness …

Hepatitis C virus (HCV) is a major public health concern, with over 70 million people infected
worldwide, who are at risk for developing life-threatening liver disease. No vaccine is …

Over the past two decades, much has been learned about how human viruses evade T cell
immunity to establish persistent infection. The lessons are particularly relevant to two …

The importance of neutralizing antibodies (NAbs) in protection against hepatitis C virus
(HCV) remains controversial. We infused a chimpanzee with H06 immunoglobulin from a …